HMM304 - Therapeutic Development

Year: 2018 unit information
Enrolment modes: Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s): 1
EFTSL value: 0.125
Unit chair:

Craig Smith


HMM202 or SLE212



Incompatible with:


Contact hours:

1 x 2 hour class per week and 1 x 1 hour (equivalent) online class per week and 1 x 1 hour seminar per week


This unit describes how therapeutic targets are identified and how new therapies are developed for human/animal use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents. This unit covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing. In particular, this unit will focus on therapeutics developed to treat cancer, chronic diseases, bacterial and viral infections.


Assessment task 1: Seminar and workshop assessments (weekly assessments) 20%

Assessment task 2: Mid-trimester test (45 minutes) 20%

Assessment task 3: Written report (1500 words) 20%

Assessment task 4: Examination (2 hours) 40%

Prescribed texts

Raymond G. Hill & Humphrey P. Rang. Drug Discovery and development second edition 2013.

Unit Fee Information

Click on the fee link below which describes you: